Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AstraZeneca And Ionis ATTR Ambitions Boosted
Efficacy of Eplontersen Maintained For 66 Weeks
Mar 27 2023
•
By
Kevin Grogan
More data added in support of eplontersen • Source: Shutterstock
More from Rare Diseases
More from Scrip